A novel method to establish microglia-free astrocyte cultures: Comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia

GLIA

Volumn 56, Issue 11, 2008, Pages 1187-1198

  Crocker, Stephen J ^a   Frausto, Ricardo F ^a   Whitton, J Lindsay ^a   Milner, Richard ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Astrocytes; Microglia; MMP

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; RIBONUCLEASE; STROMELYSIN; STROMELYSIN 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IN VITRO STUDY; MICROGLIA; MOUSE; NERVE CELL CULTURE; NEURAL STEM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; ZYMOGRAPHY;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICROGLIA;

EID: 51349134191     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20689     Document Type: Article

References (82)

1. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri M, Perry VH. 1997, Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23:406-415.
2. Arai K, Lee SR, Lo EH. 2003. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 43:254-264.
3. Ballabh P, Braun A, Nedergaard M. 2004. The blood-brain barrier: An overview. Structure, regulation and clinical implications. Neurobiol Dis 16:1-13.
4. Brunet JF, Grollimund L, Chatton JY, Lengacher S, Magistretti PJ, Villemure JG, Pellerin L. 2004. Early acquisition of typical metabolic features upon differentiation of mouse neural stem cells into astrocytes. Glia 46:8-17.
5. Carson MJ. 2002. Microglia as liasons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40:218-231.
6. Chandler S, Coats R, Gearing AJ, Lury J, Wells G, Bone E. 1995. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201:223-226.
7. Chauvet N, Palin K, Verrier D, Poole S, Dantzer R, Lestage J. 2001. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur J Neurosci 14:609-617.
8. Cossins JA, Clements JM, Ford J, Miller KM, Pigott R, Vos W, Van der Valk P, de Groot CJ. 1997. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acts. Neuropathol 94:590-598.
9. Crocker SJ, Milner R, Pham-Mitchell N, Campbell IL. 2006. Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells. J Neurochem 98:812-823.
10. Crocker SJ, Pagenstecher A, Campbell IL. 2004. The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 75:1-11.
11. Cunningham LA, Wetzel M, Rosenberg GA. 2005. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50:329-339.
12. Deb S, Wenjun Zhang J, Gottschall PE. 2003. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res 970:205-213.
13. del Zoppo GJ, Milner R. 2006. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol 26:1966-1975.
14. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J, Sciot R, Meinhardt T, Hammerling G, Opdenakker G, Arnold B. 1999. Resistance of young gelatinaseB-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104:1507-1515.
15. Falo MC, Fillmore HL, Reeves TM, Phillips LL. 2006. Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J Neurosci Res 84:768-781.
16. Fawcett J. 1997. Astrocytic and neuronal factors affecting axon regeneration in the damaged central nervous system. Cell tissue Res 290: 371-377.
17. Fawcett J, Asher RA. 1999. The glial sear and CNS repair. Brain Res Bull 49:377-391.
18. Franklin RJM, ffrench-Constant C. 1996. Transplantation and repair in multiple sclerosis. In: Russell W, editor. The molecular biology of multiple sclerosis. New York, NY: John Wiley and Sons. pp 231-242.
19. Gonzalez-Scarano F, Baltuch G. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-240.
20. Gurney KJ, Estrada EY, Rosenberg GA. 2006. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23:87-96.
21. Hamby ME, Uliasz TF, Hewett SJ, Hewett JA. 2006. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods 150:128-137.
22. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
23. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ. 1999. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624-633.
24. Hess DC, Abe T, Hill WD, Studdard AM, Carothers J, Masuya M, Fleming PA, Drake CJ, Ogawa M. 2004. Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol 186:134-144.
25. Huber JD, Egleton RD, Davis TP. 2001. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neourosci 24:719-725.
26. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320-4330.
27. Jacques TS, Relvas JB, Nishimura S, Pytela R, Edwards GM, Streuli CH, ffrench-Constant C. 1998. Neural precursor chain migration and division are regulated through different β1 integrins. Development 125:3167-3177.
28. Janzer RC, Raff MC. 1987. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325:253-257.
29. Kauppinen TM, Swanson RA. 2005. Poly (ADP-ribose) polymerase-1 promotes microglial activation, proliferation and matrix metalloproteinase-9-mediated neuron death, J Immunol 174:2288-2296.
30. Kim YS, Kim SS, Cho JJ, Choi DH, Hwang O, Shin DH, Chun HS, Beal MF, Job TH. 2005. Matrix metalloproteinase-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci 25:3701-3711.
31. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
32. Larsen PH, DaSilva AG, Conant K, Yong VW. 2006. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J Neurosci 26:2207-2214.
33. Larsen PH, Wells JE, Stallcup WB, Opdenakker G, Yong VW. 2003. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23:11127-11135.
34. Lee SR, Tsuiji K, Lo EH. 2004. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24:671-678.
35. Lee WJ, Shin CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, Ko KH. 2003. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41:15-24.
36. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100:8514-8519.
37. Lehnart S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Vartanian T. 2002. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-2486.
38. Levison SW, Druckman SK, Young GM, Basu A. 2003. Neural stem cells in the subventricular zone are a source of astrocytes and oligodendrocytes, but not microglia. Dev Neurosci 25:184-196.
39. Liu W, Rosenberg GA, Liu KJ. 2006. AUF-1 mediates inhibition by nitric oxide of lipolysaccharide-induced matrix metalloproteinase-9 expression in cultured astrocytes. J Neurosci Res 84:360-369.
40. Liuzzi GM, Mastroianni CM, Latronico T, Mengoni F, Fasano A, Lichtner M, Vullo V Riccio P. 2004. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia. Brain 127:398-407.
41. Liuzzi GM, Santacroce MP, Peumans WJ, Van Damme EJ, Dubois B, Opdenakker G, Riccio P. 1999. Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins. Glia 27:53-61.
42. Lohmann C, Krischke M, Wegener J, Galla HJ. 2004. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res 995:184-196.
43. Loo DT, Althoen MC, Cotman CW. 1995. Differentiation of serum-free mouse embryo cells into astrocytes is accompanied by induction of glutamine synthetase activity. J Neurosci Res 42:184-191.
44. Maeda A, Sobel RA. 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropath and Exp Neurol 55:300-309.
45. Milner R. 2007. A novel three-dimensional system to study interactions between endothelial cells and neural cells of the developing central nervous system. BMC Neurosci 8:3
46. Milner R, Campbell IL. 2002. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the α6β1 integrin. J Neurosci 22:1562-1572.
47. Milner R, Campbell IL. 2003. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol 170:3850-3858.
48. Milner R, Crocker SJ, Hung S, Wang X, Frausto RF, Del Zoppo GJ. 2007. Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins α5β1 and αvβ5. J Immunol 178:8158-8167.
49. Milner R, ffrench-Constant C. 1994. A developmental analysis of oligodendroglial integrins in primary cells: Changes in -associated β subunits during differentiation. Development 120:3497-3506.
50. Milner R, Hung S, Wang X, Spatz M, del Zoppo G. 2008. The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent. J Cereb Blood Flow Metab 28: 812-823.
51. Milner R, Relvas JB, Fawcett J, ffrench-Constant C. 2001. Developmental regulation of alpha v integrins produces functional changes in astrocyte behavior. Mol Cell Neurosci 18:108-118.
52. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, ellis C, Fawcett JW, Rogers JH. 2002. Matrix metallproteinases and their inhbitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100:103-117.
53. Nedergaard M, Ransom B, Goldman SA. 2003. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci 26:523-530.
54. Oh LY, Larsen PH, Krekowski CA, Edwards DR, Donovan F, Werb Z, Yong VW. 1999. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464-8475.
55. Pagenstecher A, Stalder AK, Campbell IL. 1997. RNase protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs. J Immunol Methods 206:1-9.
56. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro L, Campbell IL. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152: 729-741.
57. Proost P, Van Damme J, Opdenakker G. 1993. Leukocyte gelatinase B cleavage releases encephalitogens form human myelin basic protein. Biochem Biophys Res Comm 192:1175-1181.
58. Raivich G, Bohatschek M, Moss CU, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77-105.
59. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274:13066-13076.
60. Ransohoff RM. 1999. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines. J Neuroimmunol 98:57-68.
61. Ransom B, Behar T, Nedergaard M. 2003. New roles for astrocytes (stars at last). Trends Neurosci 26:520-522.
62. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL, Sawaya RE. 1996. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14:12-18.
63. Reynolds BA, Tetzlaff W, Weiss S. 1992. A multipotent, EGF-responsive striatal embryonic progenitor cell produces neurones and astrocytes. J Neurosci 12:4565-4574.
64. Reynolds BA, Weiss S. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1708-1709.
65. Reynolds BA, Weiss S. 1996. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1-13.
66. Rezaie P, Male D. 1999. Colonisation of the developing human brain and spinal cord by microglia: A review. Microsc Res and Tech 45:359-382.
67. Ridet J, Malhotra S, Privat A, Gage F. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20: 570-577.
68. Rosenberg GA. 2002. Matrix metalloproteinases in neuroinflammation. Glia 39:279-291.
69. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A. 2001. Immunohisto-chemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104-112.
70. Sakai Y, Rawson C, Lindburg K, Barnes D. 1990. Serum and transforming growth factor beta regulate glial fibrillary acidic protein in serum-free-derived mouse embryo cells. Proc Natl Acad Sci U S A 87:8378-8382.
71. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia. by mild trypsinization. Glia 44:183-189.
72. Shaw CE, Milner R, Compston DAS, ffrench-Constant C. 1996. Analysis of integrin expression on oligodendrocytes during axoglial interaction by using rat-mouse xenocultures. J Neurosci 16:1163-1172.
73. Shin CY, Lee WJ, Choi JW, Choi MS, Ryu JR, Oh SJ, Cheong JH, Choi EY, Ko KH. 2007. Down-regulation of matrix metalloproteinase-9 expression by nitrix oxide in lipopolysaccharide-stimulated rat primary astrocytes. Nitric Oxide 16:425-432.
74. Simard AR, Rivest S. 2004. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J 18:998-1000.
75. Tejima E, Zhao B-Q, Tsuji K, Rosell A, van Leyen K, Gonzalez RG, Montaner J, Wang X, Lo E. 2006. Astrocytic induction of matrix metalloproteinase-9 and edema after brain hemorrhage. J Cereb Blood Flow Metab 27:460-468.
76. Toft-Hansen H, Nuttall RK, Edwards DR, Owens T. 2004. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 173:5209-5218.
77. Trapp BD, Bo L, Mork S, Chang A. 1999. Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98:49-56.
78. Vos CM, van Haastert ES, de Groot CJ, van der Valk P, de Vries HE. 2003. Matrix metalloprotemase-12 is expressed in phagoctyic macrophages in active muliple sclerosis lesions. J Neuroimmunol 138:106-114.
79. Wang X, Mori T, Jung J-C, Fini ME, Lo E. 2002. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 19:615-625.
80. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS. 1996. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-392.
81. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. 2007. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697-709.
82. Yong VW, Power C, Forsyth P, Edwards DR. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502.